cd14 marker

Published on 13 June 2024 at 13:59

As a recognized leader in the creation and manufacturing of antibodies, Creative Biolabs has introduced a range of in vitro diagnostic (IVD) antibody development services for various infections and illnesses, including sepsis. Advances in science have led to the identification of novel disease biomarkers that address the need for a more rapid, precise, and accurate diagnosis of sepsis. Specifically, we offer IVD antibody development services against the CD14 marker.

Add comment

Comments

There are no comments yet.

Create Your Own Website With Webador